We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MNG:LSEM&G Plc Analysis

Data as of 2026-06-13 - not real-time

£321.60

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

M&G plc is trading at around £321.6, comfortably above its 20‑day SMA of £313 and 50‑day SMA of £303, indicating a short‑term bullish bias, but the RSI of 64 suggests the stock is edging into overbought territory. The MACD has turned bearish, and volume is on a decreasing trend, which together warn of a potential near‑term pull‑back. Fundamentally, the company posted a robust 37% revenue growth year‑over‑year and recorded net inflows of £0.6 bn in Q1, signaling renewed investor confidence. The forward PE of roughly 10× and a DCF‑derived fair value near £930 point to significant upside potential relative to the current price. However, the dividend payout ratio exceeds 160%, raising questions about the sustainability of the 6.37% yield. Overall, the mix of strong earnings momentum, attractive valuation gaps, and dividend concerns creates a nuanced outlook.
The asset‑management sector faces moderate regulatory scrutiny and is sensitive to market volatility, yet M&G’s diversified life‑insurance franchise provides a stabilising cash‑flow base. With a low beta (≈0.48) and moderate 30‑day volatility (~19%), the equity exhibits limited systematic risk, and its UK‑centric operations keep geographic and currency exposure low. Investors should weigh the short‑term technical softness against the longer‑term fundamentals and consider a cautious but optimistic positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD signal and decreasing volume
  • RSI approaching overbought levels
  • Price trading near recent resistance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value far above market price
  • Strong revenue growth and Q1 net inflows
  • Attractive forward PE around 10×

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Diversified life‑insurance and asset‑management franchise
  • High dividend yield offset by payout sustainability concerns
  • Low systematic risk (beta) and stable UK exposure

Key Metrics & Analysis

Financial Health

Revenue Growth37.00%
Profit Margin4.11%
P/E Ratio26.8
ROE9.64%
ROA0.85%
Debt/Equity216.81
P/B Ratio2.4
Op. Cash Flow£953.0M
Free Cash Flow£-3452875008
Industry P/E16.8

Technical Analysis

TrendBullish
RSI64.0
Support£302.60
Resistance£321.60
MA 20£313.36
MA 50£303.25
MA 200£285.91
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value£930.39
Target Price£308.84
Upside/Downside-3.97%
GradeUndervalued
TypeBlend
Dividend Yield6.37%

Risk Assessment

Beta0.48
Volatility19.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.